PACIRA BIOSCIENCES, INC. Convertible Debt, Current
PACIRA BIOSCIENCES, INC. (PCRX) had Convertible Debt, Current of $202.40 million as of 2025-06-30, per its 10-Q filed 2025-08-05.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Debt, Current › Long-Term Debt, Current Maturities
us-gaap:ConvertibleDebtCurrent · last filed 2025-08-05
- 2025-06-30: Convertible Debt, Current $202.40M.
- 2025-03-31: Convertible Debt, Current $202.09M.
- 2024-12-31: Convertible Debt, Current $201.78M.
- 2024-09-30: Convertible Debt, Current $201.47M.
| Period end | Convertible Debt, Current | Convertible Debt, Current as first filed |
|---|---|---|
| 2025-06-30 | $202.40M 10-Q · filed 2025-08-05 | |
| 2025-03-31 | $202.09M 10-Q · filed 2025-05-08 | |
| 2024-12-31 | $201.78M 10-Q · filed 2025-08-05 | |
| 2024-09-30 | $201.47M 10-Q · filed 2024-11-06 | |
| 2024-06-30 | $0.00 10-Q · filed 2024-07-30 | |
| 2024-03-31 | $8.64M 10-Q · filed 2024-05-07 | |
| 2023-12-31 | $8.64M 10-K · filed 2025-02-27 | |
| 2023-09-30 | $8.64M 10-Q · filed 2023-11-02 | |
| 2023-06-30 | $8.64M 10-Q · filed 2023-08-02 | |
| 2022-12-31 | $0.00 10-K · filed 2024-02-29 | |
| 2022-09-30 | $0.00 10-Q · filed 2022-11-03 | |
| 2022-06-30 | $0.00 10-Q · filed 2022-08-03 | |
| 2022-03-31 | $160.00M 10-Q · filed 2022-05-04 | |
| 2021-12-31 | $350.47M 10-K · filed 2023-02-28 | |
| 2021-09-30 | $155.75M 10-Q · filed 2021-11-03 | |
| 2021-06-30 | $153.68M 10-Q · filed 2021-08-03 | |
| 2021-03-31 | $151.65M 10-Q · filed 2021-05-04 | |
| 2020-12-31 | $149.65M 10-K · filed 2022-02-28 | |
| 2019-12-31 | $0.00 10-K · filed 2021-03-01 | |
| 2019-09-30 | $0.00 10-Q · filed 2019-11-08 | |
| 2019-06-30 | $0.00 10-Q · filed 2019-08-08 | |
| 2019-03-31 | $0.00 10-Q · filed 2019-05-02 | |
| 2018-12-31 | $338.00K 10-K · filed 2020-02-21 | |
| 2018-09-30 | $334.00K 10-Q · filed 2018-11-01 | |
| 2018-06-30 | $330.00K 10-Q · filed 2018-08-02 | |
| 2018-03-31 | $327.00K 10-Q · filed 2018-05-03 | |
| 2017-12-31 | $324.00K 10-K · filed 2019-02-28 | |
| 2017-09-30 | $320.00K 10-Q · filed 2017-11-08 | |
| 2017-06-30 | $319.00K 10-Q · filed 2017-08-02 | |
| 2017-03-31 | $759.00K 10-Q · filed 2017-05-04 | |
| 2016-12-31 | $0.00 10-K · filed 2018-02-28 | |
| 2016-09-30 | $107.56M 10-Q · filed 2016-11-02 | |
| 2016-06-30 | $106.39M 10-Q · filed 2016-08-04 | |
| 2016-03-31 | $105.22M 10-Q · filed 2016-05-02 | |
| 2015-12-31 | $104.04M 10-K · filed 2017-03-01 | $105.93M 10-K · filed 2016-02-25 |
| 2015-09-30 | $104.91M 10-Q · filed 2015-10-27 | |
| 2015-06-30 | $103.89M 10-Q · filed 2015-07-30 | |
| 2015-03-31 | $104.14M 10-Q · filed 2015-04-30 | |
| 2014-12-31 | $103.10M 10-K · filed 2016-02-25 | |
| 2014-09-30 | $102.06M 10-Q · filed 2014-10-30 | |
| 2014-06-30 | $101.03M 10-Q · filed 2014-07-31 | |
| 2014-03-31 | $100.00M 10-Q · filed 2014-05-01 | |
| 2013-12-31 | $98.96M 10-K · filed 2015-02-24 | |
| 2013-09-30 | $97.93M 10-Q · filed 2013-10-31 | |
| 2012-12-31 | $0.00 10-K · filed 2014-02-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| MANNKIND CORP (MNKD) | United States | $1.058B | -30.41 |
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 | |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |